Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Editorial · 25 May 2021Exact title match Conference abstract · 15 Jun 2020 Multidrug-resistant tuberculosis: improving response to challenge
Statement of the Problem: The Association Agreement with Europe commits Georgia to
Conference abstract · 1 Aug 2016 The possible occurrence of Extensively Drug-Resistant Tuberculosis within Multidrug-Resistant Mycobacterium tuberculosis isolates from Morocco: retrospective study
extensively drug-resistant tuberculosis (XDR-TB) has raised public Heath concern for global control of TB. Although molecular characterization of drug resistance-associated mutations in multidrug-resistant isolates in…
Case report · 29 Jul 2024 Transformative AI in Infectious Disease Management: A Case Report on Multidrug-Resistant Tuberculosis
treatments. This case report highlights AI’s transformative role in managing a complex multidrug-resistant tuberculosis (MDR-TB) case. Case representation: A 45-year-old male with untreated pulmonary tuberculosis…
Case report · 2017 Cycloserine-Induced Fever in a Patient with Multidrug-Resistant Tuberculosis and its Successful Desensitization: A Case Report
Cycloserine is one of the second-line anti-tuberculosis drugs used for treating multidrug-resistant tuberculosis (MDR-TB). Psychiatric and neurologic adverse reactions of cycloserine are commonly observed; however, fever
Case report · 4 Nov 2017 Primary Multidrug-Resistant Tuberculosis of the Breast- A Rare Presentation
culture and Drug susceptibility testing (LC-DST) confirmed it as a case of multidrug-resistant tuberculosis (MTB isolate Rifampicin and Isoniazid resistant
Conference abstract A ten-year evolution of a multidrug-resistant tuberculosis (MDR-TB) outbreak in an HIV-negative context, Tunisia (2001-2011)
Basically, almost, if not all, multidrug-resistant tuberculosis (MDR-TB) outbreaks described thus far have expanded among HIV-positive patients. Here we describe the emergence and expansion, through
Research article · 30 Jun 2020 Use of Bedaquiline as Replacement for Aminoglycosides in the Shorter Regimen for Multidrug-Resistant Tuberculosis Patients with Hearing Loss: A Report of 39 Cases in Kinshasa, Democratic Republic of the Congo
Background: Ototoxicity remains one of the major adverse events during multidrug-resistant tuberculosis (MDR-TB) treatment. It is related to the use of aminoglycosides. Bedaquiline offers an opportunity to promote
Editorial · 6 Apr 2020 Recent Advances in Effective Management of Patients with Multidrug-Resistant Tuberculosis (MDR-TB)
Tuberculosis (TB) is a major infectious disease worldwide. Most active TB disease
Research article · 7 May 2019 Multidrug-Resistant Tuberculosis Disease in North-Kivu Province, Democratique Republic of Congo
Tuberculosis (TB) burden countries in Africa.Aims and Objectives: To present prevalence and describe multidrug-resistant tuberculosis cases in North-Kivu Province identified by using Genexpert technology.Methods: We…
Conference abstract · 13 Nov 2019 Multidrug-resistant tuberculosis patients presenting with bronchiectasis and usefulness of the six-minute walk test: A case series report with literature review
Multidrug resistant tuberculosis (MDR-TB) is associated with extensive lung damage which
Mini review · 30 Mar 2022 Medication Resistant Tuberculosis
jeopardises the significant progress made in tuberculosis awareness and prevention in recent decades. Multidrug-resistant tuberculosis is caused by bacteria that are resistant to even the most powerful anti-tuberculosis…
Review article · 15 Jul 2016 Epidemiology and management of childhood multidrug-resistant tuberculosis
resistant tuberculosis (TB) in children is mainly caused by transmission of drug-resistant strains causing infection and disease (i.e., primary drug-resistant TB) and, therefore, follows adult multidrug-resistant
Mini review · 29 Apr 2023 Assessing Diagnostic Methods for Multidrug-Resistant Tuberculosis: A Comprehensive Review
Multidrug-Resistant Tuberculosis (MDR-TB) is a form of tuberculosis that is resistant to at least two of the most effective first-line anti-TB drugs: isoniazid and rifampicin
Research article · 2017 Performance Assessment of the GenoType®MTBDRplus Assay for Rapid Detection of Multidrug-Resistant Tuberculosis among Clinical Isolates in Low Tuberculosis Burden Setting
Introduction: New molecular assays for rapid Multidrug-Resistant Tuberculosis (MDR-TB) detection continue to be developed. Rwanda has recently introduced the line probe assay for early
Article · 2 Apr 2015 Prevalence of multidrug-resistant tuberculosis and convergence of MDR-TB and HIV infection
pathogens that cause more than 2 million deaths annually. On the other hand, Multidrug-resistant tuberculosis (MDRTB) caused by M. tuberculosis strains resistant to at least isoniazid (INH) and rifampin
Conference abstract · 24 Aug 2015 Use of rapid molecular test for multidrug-resistant tuberculosis detection among relapse cases in cote D’Ivoire
Tuberculosis is explicitly recognized as a major global public health problem. In Côte d'Ivoire, relapse cases represent 66.5% of patients eligible for retreatment ... according to the National Tuberclosis Control…
Conference abstract · 7 Sep 2017 Adverse events in patients with Multidrug-Resistant Tuberculosis: Results of a prospective cohort study at tertiary care level
BACKGROUND: Drug resistance Tuberculosis (DR-TB) is a public health crisis and its diagnosis and management is challenging task. One of the major obstacles in achieving successful treatment outcomes ... evaluate the…
Perspective · 3 Apr 2025 Multidrug-Resistant Tuberculosis affecting Pediatric Populations
Perspective · 22 Jul 2024 Challenges in Diagnosing and Treating Multidrug-Resistant Tuberculosis
Perspective · 2022 Determination of Multidrug-Resistant Tuberculosis Using Genotype Method
Research article · 3 May 2019 Molecular Docking Studies of Tubulosine against Multidrug-Resistant Tuberculosis
Tuberculosis (TB) causes considerable morbidity among millions of people each year worldwide
Conference abstract · 27 Sep 2018 Risks factors of multidrug-resistant tuberculosis in Casablanca-Settat Region, Morocco 2012-2016
Background: Multidrug resistance tuberculosis (MDR-TB) is defined as resistance to isoniazid

